MAPT and Alzheimer disease: The voxel-based analysis of [18-F]AV1451 PET tau showed extensive areas of posterior and middle temporal signal increase in the FTLD-AD group, in comparison with FTLD-non-AD group and this pattern of uptake is consistent with previously published literature on distribution of [18-F]AV1451 ligand in AD (47).